Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8563 |
High Similarity |
NPD3818 |
Discontinued |
0.8393 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8364 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8353 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8294 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8282 |
Intermediate Similarity |
NPD37 |
Approved |
0.8246 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8242 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8214 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8199 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8155 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8133 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8133 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8133 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8129 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8121 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8068 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8046 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7989 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7976 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7901 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7841 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7798 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7735 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD1240 |
Approved |
0.767 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7661 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.764 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7636 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7636 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7636 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7625 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7595 |
Intermediate Similarity |
NPD943 |
Approved |
0.7558 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7554 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7469 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7469 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7442 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7425 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD919 |
Approved |
0.7412 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7394 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7378 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7316 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7268 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7262 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7233 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7207 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7126 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7077 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7077 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7077 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7052 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD920 |
Approved |
0.7035 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7026 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7012 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7 |
Intermediate Similarity |
NPD7801 |
Approved |
0.6989 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.698 |
Remote Similarity |
NPD7930 |
Approved |
0.6968 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6962 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6961 |
Remote Similarity |
NPD5242 |
Approved |
0.6959 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6957 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.695 |
Remote Similarity |
NPD7874 |
Approved |
0.695 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD5353 |
Approved |
0.6946 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6941 |
Remote Similarity |
NPD2309 |
Approved |
0.6933 |
Remote Similarity |
NPD3764 |
Approved |
0.6931 |
Remote Similarity |
NPD6841 |
Approved |
0.6931 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6931 |
Remote Similarity |
NPD6842 |
Approved |
0.6927 |
Remote Similarity |
NPD6535 |
Approved |
0.6927 |
Remote Similarity |
NPD6534 |
Approved |
0.6923 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD5401 |
Approved |
0.6919 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6915 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6907 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6907 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6884 |
Remote Similarity |
NPD7584 |
Approved |
0.6882 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6875 |
Remote Similarity |
NPD1283 |
Approved |
0.6872 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6869 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6869 |
Remote Similarity |
NPD8319 |
Approved |
0.6855 |
Remote Similarity |
NPD1608 |
Approved |
0.6853 |
Remote Similarity |
NPD5005 |
Approved |
0.6853 |
Remote Similarity |
NPD5006 |
Approved |
0.6848 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6845 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD2403 |
Approved |
0.6829 |
Remote Similarity |
NPD3268 |
Approved |
0.6828 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6824 |
Remote Similarity |
NPD2654 |
Approved |
0.6823 |
Remote Similarity |
NPD7296 |
Approved |
0.6813 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6811 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.681 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6805 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6786 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6784 |
Remote Similarity |
NPD7003 |
Approved |
0.678 |
Remote Similarity |
NPD5089 |
Approved |
0.678 |
Remote Similarity |
NPD5090 |
Approved |
0.678 |
Remote Similarity |
NPD6386 |
Approved |
0.678
|
Remote Similarity |
NPD6385 |
Approved |